Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06997406Not ApplicableNot Yet Recruiting

'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss

Role: lead

NCT06738446Not ApplicableCompleted

Dietary Supplementation on Tear Secretion and Inflammation in DES

Role: collaborator

NCT01677689Phase 2Not Yet Recruiting

Study to Investigate the Efficacy and Safety of Apomivir®

Role: lead

NCT04718831Not ApplicableCompleted

Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients

Role: collaborator

All 4 trials loaded